Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,currency,priceHint,shortName,exchange,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,exchangeDataDelayedBy,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingAnnualDividendRate,trailingAnnualDividendYield,epsTrailingTwelveMonths,marketState,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,market,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,website,maxAge,address1,fax,industry
t0,HAEK.DE,88801923.0,5229310,,,-980578,,-1005463,1698945,4341205,197491,197491,2018746,-187835,,,,24886,61262402,61064910,56921197,-1178069,,-1005463,-1005463,2094302.0,43578284.0,125479913.0,27823237.0,169058197.0,4753916.0,58499539.0,22255964.0,112175.0,34583688.0,98470033.0,1435914.0,7541941.0,42925211.0,98573005.0,2103180.0,118977461.0,9863652.0,2749552.0,15066947.0,35119482.0,13027575.0,1473081,-231603,-450129,-770610,895631,2398519,5347612,426022,634,3784623,-1487436,-320481,1261155,-57329,76052250.0,en-US,US,EQUITY,False,Delayed Quote,25.2,1630510583,-0.29999924,25.1,25.3,25.0,1839,-2.7345066,-0.097889915,131778616,0.9543647,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,HAEMATO AG  INH O.N.,GER,26.405,27.011429,-1.8114281,-0.06706154,27.934507,0,finmb_6353086,XETRA,HAEMATO AG,EUR,3588,4251,6.700001,0.3621622,18.5 - 37.1,-11.899998,-0.32075468,18.5,37.1,1630391400,1630391400,1630391400,1.0,0.039215688,-2.023,REGULAR,-1.1764675,25.0 - 25.3,25.5,25.0,25.3,de_market,1.41,,,37.1,18.5,27.01,27.93,3.59k,4.25k,5.23M,,1.48M,0.00%,2.42%,,,,,,1,3.77%,1.00,3.92%,,0.00%,,"Jul 14, 2021",1:10,"Sep 02, 2020","Dec 31, 2020","Dec 31, 2020",-2.03%,0.68%,0.68%,-4.89%,238.33M,99.81,18.00%,17.69M,2.78M,-4.83M,-2.02,,10.29M,2.17,1.08M,0.86,2.77,26.41,14.67M,-52.06M,Value,12529,Healthcare,132,"HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV/AIDS, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, medical laboratories, and hospitals. The company was founded in 1993 and is headquartered in SchÃ¶nefeld, Germany.",SchÃ¶nefeld,49 30 897 30 86 70,Germany,http://www.haemato.ag,86400,Lilienthalstrasse 5c,49 30 897 30 86 79,Drug Manufacturers—Specialty & Generic
t-1,HAEK.DE,88801923.0,5229310,,,-980578,,-1005463,1698945,4341205,197491,197491,2018746,-187835,,,,24886,61262402,61064910,56921197,-1178069,,-1005463,-1005463,2094302.0,43578284.0,125479913.0,27823237.0,169058197.0,4753916.0,58499539.0,22255964.0,112175.0,34583688.0,98470033.0,1435914.0,7541941.0,42925211.0,98573005.0,2103180.0,118977461.0,9863652.0,2749552.0,15066947.0,35119482.0,13027575.0,1473081,-231603,-450129,-770610,895631,2398519,5347612,426022,634,3784623,-1487436,-320481,1261155,-57329,76052250.0,en-US,US,EQUITY,False,Delayed Quote,25.2,1630510583,-0.29999924,25.1,25.3,25.0,1839,-2.7345066,-0.097889915,131778616,0.9543647,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,HAEMATO AG  INH O.N.,GER,26.405,27.011429,-1.8114281,-0.06706154,27.934507,0,finmb_6353086,XETRA,HAEMATO AG,EUR,3588,4251,6.700001,0.3621622,18.5 - 37.1,-11.899998,-0.32075468,18.5,37.1,1630391400,1630391400,1630391400,1.0,0.039215688,-2.023,REGULAR,-1.1764675,25.0 - 25.3,25.5,25.0,25.3,de_market,1.41,,,37.1,18.5,27.01,27.93,3.59k,4.25k,5.23M,,1.48M,0.00%,2.42%,,,,,,1,3.77%,1.00,3.92%,,0.00%,,"Jul 14, 2021",1:10,"Sep 02, 2020","Dec 31, 2020","Dec 31, 2020",-2.03%,0.68%,0.68%,-4.89%,238.33M,99.81,18.00%,17.69M,2.78M,-4.83M,-2.02,,10.29M,2.17,1.08M,0.86,2.77,26.41,14.67M,-52.06M,Value,12529,Healthcare,132,"HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV/AIDS, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, medical laboratories, and hospitals. The company was founded in 1993 and is headquartered in SchÃ¶nefeld, Germany.",SchÃ¶nefeld,49 30 897 30 86 70,Germany,http://www.haemato.ag,86400,Lilienthalstrasse 5c,49 30 897 30 86 79,Drug Manufacturers—Specialty & Generic
t-2,HAEK.DE,31295143.0,5229310,,,-1300381,,-1409936,1723505,4502484,612551,612551,1748510,-213886,,,,109555,57904141,57291591,53401657,-1912932,,-1409936,-1409936,38103693.0,43875680.0,69398836.0,27922854.0,113274516.0,22867154.0,510229.0,24266891.0,177209.0,,22264791.0,134768.0,3129706.0,43372824.0,22367791.0,1900512.0,61289507.0,11846036.0,2550397.0,12410447.0,42688728.0,14621188.0,-4366789,-190615,-1131701,-1475177,-531479,321983,1987774,417920,1434,6376075,-12802,-343476,1514785,-31568,17916683.0,en-US,US,EQUITY,False,Delayed Quote,25.2,1630510583,-0.29999924,25.1,25.3,25.0,1839,-2.7345066,-0.097889915,131778616,0.9543647,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,HAEMATO AG  INH O.N.,GER,26.405,27.011429,-1.8114281,-0.06706154,27.934507,0,finmb_6353086,XETRA,HAEMATO AG,EUR,3588,4251,6.700001,0.3621622,18.5 - 37.1,-11.899998,-0.32075468,18.5,37.1,1630391400,1630391400,1630391400,1.0,0.039215688,-2.023,REGULAR,-1.1764675,25.0 - 25.3,25.5,25.0,25.3,de_market,1.41,,,37.1,18.5,27.01,27.93,3.59k,4.25k,5.23M,,1.48M,0.00%,2.42%,,,,,,1,3.77%,1.00,3.92%,,0.00%,,"Jul 14, 2021",1:10,"Sep 02, 2020","Dec 31, 2020","Dec 31, 2020",-2.03%,0.68%,0.68%,-4.89%,238.33M,99.81,18.00%,17.69M,2.78M,-4.83M,-2.02,,10.29M,2.17,1.08M,0.86,2.77,26.41,14.67M,-52.06M,Value,12529,Healthcare,132,"HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV/AIDS, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, medical laboratories, and hospitals. The company was founded in 1993 and is headquartered in SchÃ¶nefeld, Germany.",SchÃ¶nefeld,49 30 897 30 86 70,Germany,http://www.haemato.ag,86400,Lilienthalstrasse 5c,49 30 897 30 86 79,Drug Manufacturers—Specialty & Generic
t-3,HAEK.DE,31295143.0,5229310,,,-1300381,,-1409936,1723505,4502484,612551,612551,1748510,-213886,,,,109555,57904141,57291591,53401657,-1912932,,-1409936,-1409936,38103693.0,43875680.0,69398836.0,27922854.0,113274516.0,22867154.0,510229.0,24266891.0,177209.0,,22264791.0,134768.0,3129706.0,43372824.0,22367791.0,1900512.0,61289507.0,11846036.0,2550397.0,12410447.0,42688728.0,14621188.0,-4366789,-190615,-1131701,-1475177,-531479,321983,1987774,417920,1434,6376075,-12802,-343476,1514785,-31568,17916683.0,en-US,US,EQUITY,False,Delayed Quote,25.2,1630510583,-0.29999924,25.1,25.3,25.0,1839,-2.7345066,-0.097889915,131778616,0.9543647,15,Europe/Berlin,CEST,7200000,False,False,EUR,2,HAEMATO AG  INH O.N.,GER,26.405,27.011429,-1.8114281,-0.06706154,27.934507,0,finmb_6353086,XETRA,HAEMATO AG,EUR,3588,4251,6.700001,0.3621622,18.5 - 37.1,-11.899998,-0.32075468,18.5,37.1,1630391400,1630391400,1630391400,1.0,0.039215688,-2.023,REGULAR,-1.1764675,25.0 - 25.3,25.5,25.0,25.3,de_market,1.41,,,37.1,18.5,27.01,27.93,3.59k,4.25k,5.23M,,1.48M,0.00%,2.42%,,,,,,1,3.77%,1.00,3.92%,,0.00%,,"Jul 14, 2021",1:10,"Sep 02, 2020","Dec 31, 2020","Dec 31, 2020",-2.03%,0.68%,0.68%,-4.89%,238.33M,99.81,18.00%,17.69M,2.78M,-4.83M,-2.02,,10.29M,2.17,1.08M,0.86,2.77,26.41,14.67M,-52.06M,Value,12529,Healthcare,132,"HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV/AIDS, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, medical laboratories, and hospitals. The company was founded in 1993 and is headquartered in SchÃ¶nefeld, Germany.",SchÃ¶nefeld,49 30 897 30 86 70,Germany,http://www.haemato.ag,86400,Lilienthalstrasse 5c,49 30 897 30 86 79,Drug Manufacturers—Specialty & Generic
